AU2017412681B2 - System and process for treatment of myopia - Google Patents
System and process for treatment of myopia Download PDFInfo
- Publication number
- AU2017412681B2 AU2017412681B2 AU2017412681A AU2017412681A AU2017412681B2 AU 2017412681 B2 AU2017412681 B2 AU 2017412681B2 AU 2017412681 A AU2017412681 A AU 2017412681A AU 2017412681 A AU2017412681 A AU 2017412681A AU 2017412681 B2 AU2017412681 B2 AU 2017412681B2
- Authority
- AU
- Australia
- Prior art keywords
- eye tissue
- eye
- pulsed energy
- tissue
- pulsed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 100
- 230000008569 process Effects 0.000 title claims abstract description 83
- 208000001491 myopia Diseases 0.000 title claims abstract description 37
- 230000004379 myopia Effects 0.000 title claims abstract description 36
- 238000011282 treatment Methods 0.000 title claims description 159
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims abstract description 38
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims abstract description 38
- 230000006378 damage Effects 0.000 claims abstract description 37
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 27
- 230000004913 activation Effects 0.000 claims abstract description 20
- 230000000069 prophylactic effect Effects 0.000 claims abstract description 8
- 230000002207 retinal effect Effects 0.000 claims description 56
- 230000000451 tissue damage Effects 0.000 claims description 15
- 231100000827 tissue damage Toxicity 0.000 claims description 15
- 230000004936 stimulating effect Effects 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 description 113
- 210000001508 eye Anatomy 0.000 description 92
- 210000001525 retina Anatomy 0.000 description 65
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 29
- 230000003287 optical effect Effects 0.000 description 25
- 230000000694 effects Effects 0.000 description 23
- 210000000695 crystalline len Anatomy 0.000 description 18
- 230000007246 mechanism Effects 0.000 description 18
- 230000008901 benefit Effects 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 230000000649 photocoagulation Effects 0.000 description 14
- 206010064930 age-related macular degeneration Diseases 0.000 description 13
- 208000002780 macular degeneration Diseases 0.000 description 13
- 206010012689 Diabetic retinopathy Diseases 0.000 description 12
- 230000004304 visual acuity Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000004393 visual impairment Effects 0.000 description 11
- 208000017442 Retinal disease Diseases 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 10
- 102000004127 Cytokines Human genes 0.000 description 8
- 108090000695 Cytokines Proteins 0.000 description 8
- 206010025421 Macule Diseases 0.000 description 8
- 230000010455 autoregulation Effects 0.000 description 8
- 230000001684 chronic effect Effects 0.000 description 8
- 238000001126 phototherapy Methods 0.000 description 8
- 230000004243 retinal function Effects 0.000 description 8
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 7
- 206010038923 Retinopathy Diseases 0.000 description 7
- 201000011190 diabetic macular edema Diseases 0.000 description 7
- 230000000750 progressive effect Effects 0.000 description 7
- 206010057430 Retinal injury Diseases 0.000 description 6
- 230000002411 adverse Effects 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 230000017525 heat dissipation Effects 0.000 description 6
- 238000013532 laser treatment Methods 0.000 description 6
- 231100000518 lethal Toxicity 0.000 description 6
- 230000001665 lethal effect Effects 0.000 description 6
- 230000008439 repair process Effects 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 208000010412 Glaucoma Diseases 0.000 description 5
- 230000005779 cell damage Effects 0.000 description 5
- 208000037887 cell injury Diseases 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 230000005451 protein repair Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 231100000241 scar Toxicity 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 201000004569 Blindness Diseases 0.000 description 4
- 235000005459 Digitaria exilis Nutrition 0.000 description 4
- 240000008570 Digitaria exilis Species 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000004323 axial length Effects 0.000 description 4
- 230000003915 cell function Effects 0.000 description 4
- 230000007012 clinical effect Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 210000001328 optic nerve Anatomy 0.000 description 4
- 201000007914 proliferative diabetic retinopathy Diseases 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 230000004382 visual function Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000003569 Central serous chorioretinopathy Diseases 0.000 description 3
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000004308 accommodation Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001066 destructive effect Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000005670 electromagnetic radiation Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 208000030533 eye disease Diseases 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000013307 optical fiber Substances 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 208000005590 Choroidal Neovascularization Diseases 0.000 description 2
- 206010060823 Choroidal neovascularisation Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000001344 Macular Edema Diseases 0.000 description 2
- 206010025415 Macular oedema Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000022873 Ocular disease Diseases 0.000 description 2
- 206010030348 Open-Angle Glaucoma Diseases 0.000 description 2
- 206010038848 Retinal detachment Diseases 0.000 description 2
- 208000014139 Retinal vascular disease Diseases 0.000 description 2
- 208000027073 Stargardt disease Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000008512 biological response Effects 0.000 description 2
- 230000004637 cellular stress Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000011325 dry age related macular degeneration Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 201000010230 macular retinal edema Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100001160 nonlethal Toxicity 0.000 description 2
- 230000004309 orthophoria Effects 0.000 description 2
- 238000013021 overheating Methods 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 230000004515 progressive myopia Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000004517 retinal physiology Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000007135 Retinal Neovascularization Diseases 0.000 description 1
- 201000007737 Retinal degeneration Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047555 Visual field defect Diseases 0.000 description 1
- 231100000818 accidental exposure Toxicity 0.000 description 1
- 230000002350 accommodative effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 230000004329 axial myopia Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 201000008615 cone dystrophy Diseases 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 230000036040 emmetropia Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000004423 myopia development Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000006432 protein unfolding Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004331 refractive myopia Effects 0.000 description 1
- 230000000246 remedial effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000004258 retinal degeneration Effects 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 230000004283 retinal dysfunction Effects 0.000 description 1
- 230000004262 retinal health Effects 0.000 description 1
- 230000004287 retinal location Effects 0.000 description 1
- 230000004508 retinal signalling Effects 0.000 description 1
- 230000004268 retinal thickening Effects 0.000 description 1
- 208000004644 retinal vein occlusion Diseases 0.000 description 1
- 210000001210 retinal vessel Anatomy 0.000 description 1
- 238000011268 retreatment Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 201000003772 severe nonproliferative diabetic retinopathy Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000007853 structural degeneration Effects 0.000 description 1
- 210000002301 subretinal fluid Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0002—Head or parts thereof
- A61F2007/0004—Eyes or part of the face surrounding the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00863—Retina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0642—Irradiating part of the body at a certain distance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/583,096 US10953241B2 (en) | 2012-05-25 | 2017-05-01 | Process for providing protective therapy for biological tissues or fluids |
| US15/583,096 | 2017-05-01 | ||
| US15/629,002 US10278863B2 (en) | 2016-03-21 | 2017-06-21 | System and process for treatment of myopia |
| US15/629,002 | 2017-06-21 | ||
| PCT/US2017/064708 WO2018203930A1 (fr) | 2017-05-01 | 2017-12-05 | Système et procédé de traitement de la myopie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2017412681A1 AU2017412681A1 (en) | 2019-10-31 |
| AU2017412681B2 true AU2017412681B2 (en) | 2019-11-14 |
Family
ID=64016725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2017412681A Active AU2017412681B2 (en) | 2017-05-01 | 2017-12-05 | System and process for treatment of myopia |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3618923A1 (fr) |
| JP (2) | JP2020518317A (fr) |
| CN (1) | CN110582238A (fr) |
| AU (1) | AU2017412681B2 (fr) |
| BR (1) | BR112019023061A2 (fr) |
| CA (1) | CA3058891A1 (fr) |
| SG (1) | SG11201909214YA (fr) |
| WO (1) | WO2018203930A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10709608B2 (en) | 2016-03-21 | 2020-07-14 | Ojai Retinal Technology, Llc | System and process for prevention of myopia |
| WO2020251609A1 (fr) * | 2019-06-13 | 2020-12-17 | Ojai Retinal Technology, Llc | Système et procédé de prévention de la myopie |
| CN112386806A (zh) * | 2020-10-10 | 2021-02-23 | 深圳敬中堂科技有限公司 | 一种矫治视蛋白基因相关视觉疾病的光源组合及应用 |
| CN113244045A (zh) * | 2021-07-15 | 2021-08-13 | 中山大学中山眼科中心 | 一种高效视力恢复方法及其设备 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6129722A (en) * | 1999-03-10 | 2000-10-10 | Ruiz; Luis Antonio | Interactive corrective eye surgery system with topography and laser system interface |
| US20070115431A1 (en) * | 2003-11-19 | 2007-05-24 | Smith Earl L Iii | Methods and apparatuses for altering relative curvature of field and positions of peripheral, off-axis focal positions |
| US20090198309A1 (en) * | 2007-07-18 | 2009-08-06 | Visualase, Inc. | Systems and methods for thermal therapy |
| US20100049180A1 (en) * | 2007-10-19 | 2010-02-25 | Lockheed Martin Corporation | System and method for conditioning animal tissue using laser light |
| US20100100162A1 (en) * | 2008-10-22 | 2010-04-22 | Peyman Gholam A | Controlled biothermotherapy |
| US20110306956A1 (en) * | 2010-01-07 | 2011-12-15 | Cheetah Omni, Llc | Laser-based method and system for selectively processing target tissue material in a patient and optical catheter assembly for use therein |
| US20130110095A1 (en) * | 2011-10-26 | 2013-05-02 | Brian S. Boxer Wachler | Method of correcting vision problems using only a photodisruption laser |
| US20140121631A1 (en) * | 2012-11-01 | 2014-05-01 | Seminex Corporation | Variable Intensity Laser Treatments of the Skin |
| US20170319383A1 (en) * | 2016-03-21 | 2017-11-09 | Ojai Retinal Technology, Llc | System and process for treatment of myopia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6090100A (en) * | 1992-10-01 | 2000-07-18 | Chiron Technolas Gmbh Ophthalmologische Systeme | Excimer laser system for correction of vision with reduced thermal effects |
| CN2817788Y (zh) * | 2005-07-19 | 2006-09-20 | 冯丹藜 | 自动变频激光弱视治疗仪 |
| US9427602B2 (en) * | 2012-05-25 | 2016-08-30 | Ojai Retinal Technology, Llc | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair |
| US10531908B2 (en) * | 2012-05-25 | 2020-01-14 | Ojai Retinal Technology, Llc | Method for heat treating biological tissues using pulsed energy sources |
| EP3250139A4 (fr) * | 2015-01-28 | 2018-06-27 | Ojai Retinal Technology, LLC | Thérapie électromagnétique pulsée et par ultrasons pour stimuler des protéines de choc thermique ciblées et faciliter une réparation de protéine |
| WO2017069819A1 (fr) * | 2015-10-23 | 2017-04-27 | Ojai Retinal Technology, Llc | Système et procédé pour photothérapie de la rétine |
-
2017
- 2017-12-05 EP EP17908615.2A patent/EP3618923A1/fr not_active Withdrawn
- 2017-12-05 CA CA3058891A patent/CA3058891A1/fr active Pending
- 2017-12-05 SG SG11201909214Y patent/SG11201909214YA/en unknown
- 2017-12-05 AU AU2017412681A patent/AU2017412681B2/en active Active
- 2017-12-05 JP JP2019554563A patent/JP2020518317A/ja active Pending
- 2017-12-05 BR BR112019023061A patent/BR112019023061A2/pt not_active Application Discontinuation
- 2017-12-05 CN CN201780090319.XA patent/CN110582238A/zh active Pending
- 2017-12-05 WO PCT/US2017/064708 patent/WO2018203930A1/fr unknown
-
2022
- 2022-09-08 JP JP2022143131A patent/JP2022184907A/ja active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6129722A (en) * | 1999-03-10 | 2000-10-10 | Ruiz; Luis Antonio | Interactive corrective eye surgery system with topography and laser system interface |
| US20070115431A1 (en) * | 2003-11-19 | 2007-05-24 | Smith Earl L Iii | Methods and apparatuses for altering relative curvature of field and positions of peripheral, off-axis focal positions |
| US20090198309A1 (en) * | 2007-07-18 | 2009-08-06 | Visualase, Inc. | Systems and methods for thermal therapy |
| US20100049180A1 (en) * | 2007-10-19 | 2010-02-25 | Lockheed Martin Corporation | System and method for conditioning animal tissue using laser light |
| US20100100162A1 (en) * | 2008-10-22 | 2010-04-22 | Peyman Gholam A | Controlled biothermotherapy |
| US20110306956A1 (en) * | 2010-01-07 | 2011-12-15 | Cheetah Omni, Llc | Laser-based method and system for selectively processing target tissue material in a patient and optical catheter assembly for use therein |
| US20130110095A1 (en) * | 2011-10-26 | 2013-05-02 | Brian S. Boxer Wachler | Method of correcting vision problems using only a photodisruption laser |
| US20140121631A1 (en) * | 2012-11-01 | 2014-05-01 | Seminex Corporation | Variable Intensity Laser Treatments of the Skin |
| US20170319383A1 (en) * | 2016-03-21 | 2017-11-09 | Ojai Retinal Technology, Llc | System and process for treatment of myopia |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3618923A4 (fr) | 2020-03-11 |
| SG11201909214YA (en) | 2019-11-28 |
| BR112019023061A2 (pt) | 2020-06-09 |
| WO2018203930A1 (fr) | 2018-11-08 |
| AU2017412681A1 (en) | 2019-10-31 |
| CN110582238A (zh) | 2019-12-17 |
| JP2020518317A (ja) | 2020-06-25 |
| CA3058891A1 (fr) | 2018-11-08 |
| JP2022184907A (ja) | 2022-12-13 |
| EP3618923A1 (fr) | 2020-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10709607B2 (en) | System and process for treatment of myopia | |
| US10278865B2 (en) | Process for neuroprotective therapy for glaucoma | |
| US10285859B2 (en) | System for performing retina photostimulation | |
| AU2021215167B2 (en) | System and process for retina phototherapy | |
| AU2017412681B2 (en) | System and process for treatment of myopia | |
| JP2018531051A6 (ja) | 網膜光線療法のためのシステムとプロセス | |
| US10709608B2 (en) | System and process for prevention of myopia | |
| EP3451983B1 (fr) | Système pour une thérapie neuroprotectrice pour le glaucome | |
| WO2020251609A1 (fr) | Système et procédé de prévention de la myopie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |